Synopsis
The serum C-peptide immunoreactivity (CPR) in diabetics never on insulin was reported to be low (Heding, 1975) . However, insulin-treated diabetics were found to have rather higher CPR levels than healthy subjects (Block et al., 1972) . The sera of insulin-treated diabetics were also found to contain a large amount of proinsulin-like components (PLC) (Block et al., 1972; Fink et al., 1974) . As these diabetics had circulating insulin antibodies, it was supposed that the secreted PLC was bound to insulin antibodies and accumulated in the circulation. These PLC-insulin antibody complexes will cross-react with human C-peptide antiserum and may be responsible for the circulating higher CPR levels in some of insulin-treated diabetics. The recent study reported that over 80% of serum CPR in insulin-treated diabetics was actually proinsulin, and the necessity to remove the PLC-insulin antibody complexes before assay was suggested for evaluating the endogenous insulin secretion in insulin-treated diabetics accurately (Horwitz et al., 1976) . In this report, a simple method to measure the serum CPR in insulin-treated diabetics after the removal of PLC-insulin antibody complexes will be described.
Materials and Methods
The 
Results and Discussion
Following the direct gel filtrations of sera of insulin-treated diabetics, two major peaks of CPR were found ; one was at the position corresponding to serum protein and the other was at the position not associated with serum protein (Fig. 2, left lower panel) . In contrast, the sera of healthy subjects had no CPR at the position of serum protein (Fig. 2, left upper panel) . The CPR found at the position corresponding to serum protein by the neutral gel filtration of serum from insulin-treated diabetics may be attributed to PLC-insulin antibody complexes, because a considerable amount of PLC was detected from the serum extract after acidic gel chromatography (Fig. 2, right lower  panel) .
The gamma globulin (including PLCinsulin antibody complexes) were precipitated by the addition of PEG to the serum, but the free peptide hormones such as insulin and growth hormone were not precipitated (Desbuquois and Aurbach, 1971 ). The Cpeptide added to human serum was not precipitated by this method and therefore the CPR determined from PEG-treated serum will represent the free C-peptide concentration (and possibly a small amount of free PLC).
In the free CPR assay system, normal sheep serum 0.05ml was added to each assay tube containing PEG-treated serum sample in order to equalize the immunore- insulin-treated diabetic subjects were also observed by the gel filtrations of their serum extracts.
In agreement with the previous reports (Block et al., 1972 ; Fink et al., 1974) , a large amount of PLC was Fig. 4 . Total and free CPR before and 60 min after glucose load. The total and free CPR values in subjects never on insulin (•)) (7 healthy subjects and 25 adults onset diabetics) were well correlated with each other (r=0.962 for fasting, r=0.983 for 60min after glucose). In contrast, the free CPR in insulin-treated diabetics (O) was significantly lower than the total CPR before and after glucose. Each one case of the healthy subject (•*) and inby gel filtrations, and the results were shown in Fig. 2 . Table 1 . Recovery of synthetic human C-peptide in free CPR assay Each of 2.5ng, 5.0ng and 10.0ng of synthetic human C-peptide was added to 1 ml of pooled fasting human sera, and assayed for their free CPR contents. found only in insulin-treated patients after acidic gel filtration. The variability of F/T among insulin-treated diabetics may be attributed to the character of insulin antibodies capable of binding endogenous PLC. The higher ratios of F/T after glucose may account for the responses of endogenous C-peptide (or insulin) to glucose.
It was noteworthy that the measurement of the total CPR in insulin-treated diabetics was very useful for monitoring the B-cell secretory function, but the values obtained by this method could not be compared to those in subjects without insulin treatment (Horwitz etal., 1976) . The presented free CPR assay was thought to obviate this difficulty.
